QURE uniQure NV

Price (delayed)

$31.71

Market cap

$1.46B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.09

Enterprise value

$1.3B

Sector: Healthcare
Industry: Biotechnology

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights

The debt rose by 47% QoQ and by 45% YoY
The quick ratio is down by 34% year-on-year and by 10% since the previous quarter

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
46.02M
Market cap
$1.46B
Enterprise value
$1.3B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.24
Price to sales (P/S)
38.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.43
Earnings
Revenue
$37.86M
EBIT
-$150.39M
EBITDA
-$139.61M
Free cash flow
-$153.62M
Per share
EPS
-$3.09
Free cash flow per share
-$3.38
Book value per share
$5.08
Revenue per share
$0.83
TBVPS
$7.93
Balance sheet
Total assets
$363.85M
Total liabilities
$135.16M
Debt
$105.41M
Equity
$228.69M
Working capital
$250.23M
Liquidity
Debt to equity
0.46
Current ratio
8.79
Quick ratio
8.29
Net debt/EBITDA
1.11
Margins
EBITDA margin
-368.7%
Gross margin
100%
Net margin
-366%
Operating margin
-365.1%
Efficiency
Return on assets
-38.5%
Return on equity
-57.4%
Return on invested capital
-116.1%
Return on capital employed
-45.3%
Return on sales
-397.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
-2.25%
1 week
-1.67%
1 month
-6.93%
1 year
-45.64%
YTD
-12.23%
QTD
-5.88%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$37.86M
Gross profit
$37.86M
Operating income
-$138.26M
Net income
-$138.58M
Gross margin
100%
Net margin
-366%
The operating margin has soared by 83% YoY but it has contracted by 6% from the previous quarter
The net margin has soared by 82% YoY but it fell by 10% QoQ
The net income has declined by 11% year-on-year and by 11% since the previous quarter
QURE's operating income is down by 7% QoQ and by 6% YoY

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
6.24
P/S
38.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.43
The company's EPS fell by 10% QoQ and by 2.7% YoY
The equity is down by 23% YoY and by 6% QoQ
QURE's P/B is 21% below its 5-year quarterly average of 7.9 and 11% below its last 4 quarters average of 7.0
The P/S is 79% lower than the last 4 quarters average of 182.6 and 75% lower than the 5-year quarterly average of 153.9

Efficiency

How efficient is uniQure business performance
The company's return on sales has surged by 79% YoY but it fell by 8% QoQ
The return on equity has declined by 27% year-on-year and by 19% since the previous quarter
The ROA has contracted by 23% YoY and by 15% from the previous quarter
The return on invested capital has declined by 4.2% year-on-year but it has increased by 4% since the previous quarter

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets is 169% greater than its total liabilities
The total liabilities has grown by 40% from the previous quarter and by 13% YoY
The quick ratio is down by 34% year-on-year and by 10% since the previous quarter
The debt is 54% lower than the equity
The debt to equity has soared by 84% YoY and by 59% from the previous quarter
The debt rose by 47% QoQ and by 45% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.